The Procter & Gamble Company's Stock Analysis

Procter & Gamble Reports Q2 FY 2026 Financial Results

On January 22, 2026, Procter & Gamble announced its second quarter results, showing organic sales growth at 0% and a decline in organic volume by 1%. The core earnings per share remained steady at $1.88, consistent with the prior year. Despite challenges, seven out of ten product categories either grew or maintained organic sales. The company’s global market share decreased by 20 basis points, although 25 of the top 50 category/country combinations saw share growth or stability during the quarter.

For FY 2026, Procter & Gamble provided guidance with organic sales growth projected between 0% to 4% and net sales growth between 1% to 5%. The core earnings per share growth is also expected to be in the range of 0% to 4%. The company anticipates potential headwinds from various factors including market deceleration, currency fluctuations, and increased commodity costs, which could affect its financial performance.

Jan 22, 2026 11:53:22

Procter & Gamble Reports Q2 2026 Financial Results and Guidance

Procter & Gamble Company reported net sales of $22.2 billion for the second quarter of fiscal year 2026, reflecting a one percent increase compared to the previous year. Organic sales remained unchanged, with a one percent rise in pricing offset by a one percent decline in unit volume. The company's diluted net earnings per share decreased by five percent to $1.78, primarily due to increased restructuring charges, while core earnings per share remained steady at $1.88. Operating cash flow was reported at $5.0 billion, and the company returned $4.8 billion to shareholders through dividends and share repurchases.

For fiscal year 2026, Procter & Gamble maintained its guidance for all-in sales growth between one to five percent and organic sales growth in the range of in-line to up four percent. The diluted net earnings per share growth outlook was adjusted to a range of one to six percent, reflecting higher restructuring charges. The company expects commodity costs to be neutral for the year and anticipates a tailwind from foreign exchange rates. Procter & Gamble plans to pay around $10 billion in dividends and repurchase approximately $5 billion of common shares during the fiscal year.

Jan 22, 2026 07:02:05

Procter & Gamble Declares Quarterly Dividend of $1.0568 Per Share

The Procter & Gamble Company announced on January 13, 2026, that its Board of Directors has declared a quarterly dividend of $1.0568 per share on its Common Stock, as well as on the Series A and Series B ESOP Convertible Class A Preferred Stock. This dividend is set to be payable on or after February 17, 2026, to shareholders of record as of January 23, 2026.

This marks the continuation of P&G's long-standing practice of returning cash to shareholders, having paid dividends for 135 consecutive years and increased its dividend for 69 consecutive years. The company's commitment to maintaining a reliable income stream for investors is emphasized, highlighting its extensive portfolio of well-known consumer brands and global operations in approximately 70 countries.

Jan 13, 2026 16:27:59

CEO of Procter & Gamble Announces Retirement Effective June 2026

Jennifer Davis, the Chief Executive Officer of Health Care at Procter & Gamble, has announced her intention to retire on June 30, 2026, after over 33 years with the company. This leadership change may impact the company's strategic direction and operations as it prepares for her departure.

The announcement was made on December 9, 2025, and reflects a significant transition within the company's executive team. Investors may want to monitor the company's succession planning and any potential implications for its performance in the health care sector.

Dec 15, 2025 09:15:22

Procter & Gamble Closes $258.9 Million Note Offering

The Procter & Gamble Company has successfully completed an underwritten public offering of Floating Rate Notes, totaling $258,889,000. These notes are due on November 4, 2075 and were issued under the company's existing Registration Statement on Form S-3.

Legal opinions related to the notes have been included as part of the filing. This offering may affect the company's financial position and liquidity, which are key considerations for investors.

Nov 04, 2025 16:16:00

Procter & Gamble Closes €1 Billion and $1.25 Billion Offerings

On November 3, 2025, The Procter & Gamble Company completed an underwritten public offering totaling €500 million in 2.900% Notes due in 2033 and €500 million in 3.650% Notes due in 2045. This issuance was conducted under the company's Registration Statement on Form S-3.

Additionally, the company closed another public offering of $750 million in 4.100% Notes due in 2032 and $500 million in 4.350% Notes due in 2035, also under the same Registration Statement. Legal opinions related to these offerings have been attached as exhibits to the report.

Nov 03, 2025 16:23:10

Procter & Gamble Reports Q1 FY 2026 Financial Results

On October 24, 2025, Procter & Gamble announced its first quarter results for FY 2026, reporting a 2% growth in organic sales driven by pricing and mix, despite a challenging market environment. Core earnings per share (EPS) increased by 3% year-over-year, reaching $1.99, while organic volume growth remained flat. The company noted that 8 out of 10 product categories either grew or maintained their organic sales during this quarter, although the global aggregate value share declined by 30 basis points.

For the fiscal year 2026, Procter & Gamble provided guidance indicating expected organic sales growth of 0% to 4% and net sales growth of 1% to 5%. Core EPS is projected to grow between 0% to 4%, with all-in EPS growth anticipated to be between 3% to 9%. The company also highlighted various potential headwinds that could impact these projections, including commodity cost increases and geopolitical disruptions. Investors may want to consider these factors when assessing the company's outlook.

Oct 24, 2025 10:10:46

Procter & Gamble Reports Q1 Fiscal 2026 Financial Results

The Procter & Gamble Company reported first quarter fiscal year 2026 net sales of $22.4 billion, marking a three percent increase compared to the previous year. Organic sales, which exclude foreign exchange and acquisitions, rose two percent, driven by a one percent increase from higher pricing and a one percent increase from a favorable sales mix. Diluted net earnings per share reached $1.95, up 21% year-over-year, while core earnings per share increased three percent to $1.99. The company's operating cash flow was $5.4 billion, with net earnings totaling $4.8 billion for the quarter. P&G returned $3.8 billion to shareholders through dividend payments and share repurchases during this period.

For fiscal year 2026, Procter & Gamble maintained its guidance for all-in sales growth between one to five percent and organic sales growth in line with or up to four percent. The company anticipates diluted net earnings per share growth between three to nine percent. P&G expects commodity cost headwinds of approximately $100 million and higher tariff costs of about $400 million. Despite these challenges, the company projects a favorable foreign exchange tailwind of around $300 million after tax and plans to allocate about $10 billion for dividends and $5 billion for share repurchases in fiscal 2026.

Oct 24, 2025 07:04:27

Procter & Gamble Approves 2025 Stock Incentive Compensation Plan

At the Annual Meeting of Shareholders on October 14, 2025, Procter & Gamble shareholders approved the 2025 Stock and Incentive Compensation Plan, which allows for the award of up to 175 million shares of common stock. The plan includes various types of awards such as stock options and restricted stock units, and it also incorporates shares remaining from the 2019 Stock Plan. The Board of Directors had previously approved this plan for submission to shareholders on August 12, 2025.

During the same meeting, shareholders elected directors for a one-year term, ratified the appointment of the independent registered public accounting firm, and approved an advisory vote on executive compensation. Additionally, the 2025 Stock Plan received approval, while a shareholder proposal requesting more reporting on plastic packaging was not approved. The outcomes of these votes may have implications for the company's governance and compensation strategies.

Oct 16, 2025 16:25:14

Procter & Gamble Declares Quarterly Dividend and Board Elections

The Procter & Gamble Company announced a quarterly dividend of $1.0568 per share on both its Common Stock and Series A and Series B ESOP Convertible Class A Preferred Stock. This dividend will be payable on or after November 17, 2025, to shareholders of record as of October 24, 2025. The company has a long history of dividend payments, having paid dividends for 135 consecutive years and increased them for 69 consecutive years, highlighting its commitment to returning cash to shareholders.

During the Annual Meeting of Shareholders, all fourteen Director nominees were elected to the Board, receiving strong preliminary support. Shareholders also approved several Board proposals, including the ratification of the independent registered public accounting firm and an advisory vote on executive compensation. Additionally, a proposal for more reporting on flexible plastic packaging was voted down. Final voting results will be certified and announced in a subsequent filing.

Oct 14, 2025 10:55:51